Find an expert

Dr Lee is a mid-career researcher with training in neuroscience, and additional experience in pharmacology and immunity. He completed his Ph.D. at the University of Queensland (UQ) in 2014 and continued his post-doctoral research studies in neuroinflammation and neurodegenerative diseases. He is currently a Senior Research Fellow and Group Leader at UQ's School of Biomedical Sciences, where he focusses on innate immune and inflammatory pathways including the complement system and inflammasomes in motor neuron disease (amyotrophic lateral sclerosis), Huntington’s disease, and Parkinson’s disease. Dr Lee’s research has demonstrated the therapeutic potential of multiple anti-inflammatory drugs targeting innate immune-mediated neuroinflammation to reduce neuronal cell death in animal models of neurodegenerative disease. He is also interested in the links between the immune system, stress response, and energy metabolism in neurodegeneration.

Dr Odette Leiter is a postdoctoral research fellow in the research group of Dr Tara Walker, investigating systemic brain rejuvenation. She was awarded a PhD in Neuroscience in 2018 by the Technische Universität Dresden in Germany. Her research focus lies on the regulation of adult hippocampal neurogenesis by physical exercise, a process critically involved in learning and memory.

To support her research at the Queensland Brain Institute, Dr Odette Leiter has received two postdoctoral fellowships, a postdoctoral fellowship from the German Academic Exchange Service, followed by a Walter Benjamin Fellowship awarded by the German Research Foundation, allowing her to investigate the role of platelets in mediating neurogenesis-related learning and memory, and the capacity of platelet-released factors to restore cognitive function in ageing. More recently, Dr Leiter has been awarded a Discovery Early Career Researcher Award (DECRA) to investigate the precise mechanisms through which platelets interact with adult hippocampal neural stem cells following exercise.

Zhiqi Liang is a Specialist Musculoskeletal Physiotherapist and Lecturer in Physiotherapy at the University of Queensland. She teaches on the Master of Physiotherapy (Musculoskeletal) Program and maintains a clinical role at the Headache Clinic in the University of Queensland. Her research is on neck pain and headache, especially migraine, exploring mechanisms of neck pain in headache and treatment directions, including patient preferences, for individualised management. In 2024, she was awarded the David Lamb Award by the International Federation of Manual and Musculoskeletal Physical Therapists Incorporated (IFOMPT) for high quality research that has made an impact to musculoskeletal physiotherapy internationally. Zhiqi has been a musculoskeletal physiotherapist for more than 15 years and her clinical expertise is recognised by Fellowship within the Australian College of Physiotherapists, where she has been actively involved as an examiner and facilitator for the Specialisation Training Program and currently serves on the Board of Censors.

Professor Jason Mattingley was appointed as Foundation Chair in Cognitive Neuroscience at the University of Queensland in January 2007, a joint appointment between the Queensland Brain Institute and the School of Psychology.

He completed a Bachelor of Science Degree with Honours at Monash University (1988), a Master of Science Degree in Clinical Neuropsychology at the University of Melbourne (1990), and a PhD in Psychology at Monash University (1995). In 1994 he was awarded an NHMRC Neil Hamilton Fairley Post-Doctoral Fellowship, which he took to the University of Cambridge. Here he worked jointly with Professor Jon Driver in the Department of Experimental Psychology and Professor Ian Robertson at the MRC Cognition and Brain Sciences Unit. While in Cambridge he was elected a Fellow of King’s College.

Upon returning to Australia Professor Mattingley was appointed as Senior Research Fellow (later Principal Research Fellow) at the University of Melbourne, where he was Director of the Cognitive Neuroscience Laboratory within the School of Behavioural Science (2000 – 2006).

Professor Mattingley has won numerous accolades for his research, including an Australian Laureate Fellowship from the Australian Research Council (2012), the Distinguished Contribution to Psychological Science Award from the Australian Psychological Society (2012), and the Monash University Distinguished Alumni Award (Faculty of Biomedical and Psychological Sciences, 2016).

He was elected a Fellow of the Academy of Social Sciences in Australia in 2007, and a Fellow of the Association for Psychological Science in 2016.

Dr. Emily McCann is a Postdoctoral Research Fellow at the Dementia & Neuro Mental Health Research Unit at the University of Queensland Centre for Clinical Research. She is currently working on the development of a Parkinson's Disease specific cognitive toolkit to harmonise cognitive assessment and understand the development of dementia.

She completed her PhD in 2024 at the Cognitive Neurology (Nestor) lab at the Queensland Brain Institute. During her PhD, she investigated the nature and timing of visuoperceptual impairments across a range of neurodegenerative diseases.

John McGrath AM, MBBS, MD, PhD, FRANZCP, FAHMS

John McGrath is a psychiatrist interested in discovering the causes of serious mental disorders. He is the Director of the Queensland Centre for Mental Health Research and conjoint Professor at the Queensland Brain Institute His research aims to generate and evaluate nongenetic risk factors for schizophrenia. He has forged productive cross-disciplinary collaborations linking risk factor epidemiology with developmental neurobiology. For example, John and his colleagues have made discoveries linking prenatal vitamin D and later risk of mental illness in the offspring. In addition, John has supervised major systematic reviews of the epidemiology of schizophrenia. He was awarded a John Cade Fellowship by the Australian National Health and Medical Research Council. In 2016 he was also awarded a Neils Bohr Professorship by the Danish National Research Foundation.

Treasure McGuire graduated with a Bachelor of Pharmacy and a Bachelor of Science (Pharmacology) from the University of Queensland UQ). She also completed a Postgraduate Diploma in Clinical Pharmacy and Graduate Certificate in Higher Education at UQ. In 2005, she completed her PhD in the School of Population Health, UQ, entitled Consumer medicines call centres: a medication liaison model of pharmaceutical care.

She has held a sennior conjoint appointment between the School of Pharmacy, UQ and Mater Pharmacy, Mater Health, Brisbane since 1996, and was appointed as a Senior Lecturer in 2006. In her Mater role, she has been Assistant Director of Pharmacy (Practice and Development) over this same time period. At UQ, she coordinates a graduate clinical pharmacy course within the Master of Clinical Pharmacy program. In 2016, this program received a UQ Faculty of Health and Behavioural Sciences Team Award for Programs that Enhance Learning and in 2017 a citation in the University of Queensland Award for Excellence in Teaching and Learning.

Treasure’s research is translational, focussing on patient centred-care and quality use of medicines in the domains of medicines information, evidence-based practice, medication safety, reproductive health, complementary medicines, communicable diseases and interprofessional education. She is a Fellow of the Australian College of Pharmacy and a Fellow of the Pharmaceutical Society of Australia.In recognition of her services to medicines information, she received the Lilly International Fellowship in Hospital Pharmacy and the Bowl of Hygeia of the Pharmaceutical Society of Australia. In 2015, she was the recipient of the Sr Eileen Pollard Medal (Mater Research-UQ) for excellence in incorporating research into clinical care provision.

Professor Frederic Meunier obtained his Masters degree in Neurophysiology at the Paris XI University, France in 1992 and completed his Ph.D in Neurobiology at the CNRS in Gif-sur-Yvette, France in 1996. He was the recipient of a European Biotechnology Fellowship and went on to postgraduate work at the Department of Biochemistry at Imperial College (1997-1999) and at Cancer Research UK (2000-2002) in London, UK. After a short sabbatical at the LMB-MRC in Cambridge (UK), he became a group leader at the School of Biomedical Sciences at the University of Queensland (Australia) in 2003. He joined the Queensland Brain Institute of the University of Queensland in 2007 and obtained an NHMRC senior research fellowship in 2009 renewed in 2014 with promotion. He became Professor in 2014 at the Queensland Brain Institute and is currently part of the Centre for Ageing Dementia Research.

I received a BA in Biology from Columbia University in New York City. After taking two years off to work as a research assistant, I began graduate school at Weill Cornell Graduate School of Medical Sciences, also in New York. My graduate advisor was Andrew Koff at the Sloan-Kettering Cancer Institute. I studied the cdk inhibitor, p27, and discovered that it is regulated at the level of translation as cells exit the cell cycle. I received my PhD in Molecular Biology in 2001. My postdoctoral work was carried out in Larry Zipursky's lab at UCLA. Here, I learned both Drosophila genetics and neurobiology and began working on the Dscam-family of cell recognition molecules. I identified Dscam2 as the first tiling receptor and discovered that Dscam2 and Dscam1 are redundantly required for photoreceptor synaptic specificity. I moved to Brisbane and began as a lecturer at the UQ School of Biomedical Sciences, in December 2009. I am also an affiliate of the Queensland Brain Institute.

Dr Moni holds a PhD in Artificial Intelligence & Data Science in 2014 from the University of Cambridge, UK followed by postdoctoral training at the University of New South Wales, University of Sydney Vice-chancellor fellowship, and Senior Data Scientist at the University of Oxford. Dr Moni then joined UQ in 2021. He also worked as an assistant professor and lecturer in two universities (PUST and JKKNIU) from 2007 to 2011. He is an Artificial Intelligence, Computer Vision & Machine learning, Digital Health Data Science, Health Informatics and Bioinformatics researcher developing interpretable and clinical applicable machine learning and deep learning models to increase the performance and transparency of AI-based automated decision-making systems.

His research interests include quantifying and extracting actionable knowledge from data to solve real-world problems and giving humans explainable AI models through feature visualisation and attribution methods. He has applied these techniques to various multi-disciplinary applications such as medical imaging including stroke MRI/fMRI imaging, real-time cancer imaging. He led and managed significant research programs in developing machine-learning, deep-learning and translational data science models, and software tools to aid the diagnosis and prediction of disease outcomes, particularly for hard-to-manage complex and chronic diseases. His research interest also includes developing Data Science, machine learning and deep learning algorithms, models and software tools utilising different types of data, especially medical images, neuroimaging (MRI, fMRI, Ultrasound, X-Ray), EEG, ECG, Bioinformatics, and secondary usage of routinely collected data.

• I am currently recruiting graduate students. Check out Available Projects for details. Open to both Domestic and International students.

Dr Philip Mosley studied at the University of Oxford and obtained a masters degree in physiological sciences and a degree in medicine. He was also captain of the university boxing team and was awarded two full 'Blues'. He worked as a junior doctor in Manchester before moving to Australia to complete his specialist training in psychiatry.

Dr Mosley is a Fellow of the Royal Australian and New Zealand College of Psychiatry (RANZCP) and has completed an advanced certificate in Consultation-Liaison Psychiatry. As part of his training he also undertook a 2-year neuropsychiatry fellowship at the Royal Brisbane and Women’s Hospital (RBWH) and the Asia-Pacific Centre for Neuromodulation (APCN) at the University of Queensland. Currently, Dr Mosley works as a member of the deep brain stimulation (DBS) team at St Andrew's War Memorial Hospital, Brisbane, runs a private neuropsychiatry practice and also provides a consultation-liaison psychiatry service to the neurology, medical and surgical wards. Dr Mosley's private practice is focussed on neurodegenerative disease, movement disorders and head injury.

Dr Mosley is an active clinician-scientist with appointments at the QIMR Berghofer Medical Research Institute, Queensland Brain Institute and CSIRO. He completed his PhD in neuroscience in 2019 under the supervision of Professor Michael Breakspear. He published eleven peer-reviewed manuscripts and received the UQ Dean's Award for outstanding thesis. Dr Mosley has been the chief investigator in a study of the neuropsychiatric effects of DBS for Parkinson’s disease, in a study of medicinal cannabis for Tourette’s syndrome, a lead investigator in a clinical trial of DBS for obsessive-compulsive disorder and anorexia nervosa, as well as a clinical fellow in a neuroimaging study of Alzheimer’s disease. He has won prizes from the RANZCP in Old Age Psychiatry and Consultation-Liaison Psychiatry, and he has received research funding from the RBWH Foundation, the RANZCP Young Investigator Grant, Parkinson’s Queensland and Wesley Medical Research. Dr Mosley was awarded an ‘Advance Queensland’ Early Career Fellowship for his Parkinson's disease research and won the postgraduate medal from the Australian Society for Medical Research for findings arising from this project. In 2020, he won the Early Career Psychiatrist award from the RANZCP, which is presented to the fellow producing the most significant piece of research in the five years since fellowship. Currently Dr Mosley's research is funded by the National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund.

If you wish to contact Dr Mosley regarding a clinical matter, please do so via his neuropsychiatry clinic (Neurosciences Queensland) telephone: 07 3839 3688 or email: admin@nsqld.com.au.

Bryan is a graduate in medicine from the University of Queensland and holds a BA (Hons) degree in philosophy from the University of Western Australia. A medical specialist in psychiatry, he is a clinician researcher, who is Conjoint Professor at the Queensland Brain Institute, University of Queensland, and Director of Genetics at the Queensland Centre for Mental Health Research. His primary research interest is the molecular genetics of schizophrenia, and holds a MD degree (University of Queensland) in this field. Since 1990, he has conducted studies, with national and international collaborators, to identify susceptibility genes for this disorder. He is the recipient of grants from the Australian NHMRC and the US NIMH.

The primary research goal is to identify and functionally characterise susceptibility genes for schizophrenia and related disorders. A special focus is on the study of large collaborative samples and ethnically homogeneous populations. Key methodologies used in the lab include genome-wide association studies, next-generation sequencing, transcriptome profiling of post-mortem brain samples, neurocognitive and neuroimaging phenotyping and induced pluripotent stem cells.

Current areas of interest include pharmacogenomics of clozapine treatment response, whole exome sequencing focused on de novo mutations, and the neuroimmunology of schizophrenia

Prof Nestor joined the Queensland Brain Institute in October/2017 and has a conjoint appointment as a cognitive neurologist at Mater Misericordiae Ltd (Mater Hospital).

His particular interests include understanding the earliest stages of Alzheimer's disease (i.e. before dementia is established); atypical forms of dementia with a particular focus on primary progressive aphasia and dementias related to Parkinson's and Lewy body diseases; and improving differential diagnosis between the major categories of neurodegenerative diseases.

He works on development of neuropsychological tests of cognition, both to accurately track change over time and improve diagnostic accuracy between the major diseases causing dementia. He also uses multi-modal imaging (magnetic resonance imaging [MRI] and positron emission tomography [PET]) to understand the sequence of events occurring in degenerative brain diseases (particularly Alzheimer's disease, frontotemporal dementia, Parkinson's disease, motor neuron disease [ALS], progressive supranuclear palsy [PSP] and corticobasal degeneration [CBD]) and identify novel biomarkers. A major focus of his is on developing novel approaches to MR imaging for single subject pathological diagnoses that can be exported into the everyday clinical setting; recent examples include diffusion tensor imaging to identify PSP and CBD (Sajjadi et al, 2013) and quantitative susceptibility mapping in Parkinson's disease (Acosta-Cabornero et al, 2013).

Dr Dominic Ng graduated with a BSc (Hons) and gained his PhD from the University of Western Australia. His doctoral studies, conducted in the laboratory of Assoc. Prof. Marie Bogoyevitch, were focused on cardiomyocyte signalling mechanisms regulating pathological tissue growth (ie cardiac hypertrophy). He continued his research training in Singapore as a post-doctoral research fellow based at the Institute of Molecular and Cell Biology, the flagship institute of Singapore’s science agency (A*STAR) located at the world renowned Biopolis research precinct. During this time, his research interests turned to the complex regulation of the cytoskeleton and their functions in development and disease.

He returned to the Australian medical research community on an NHMRC Peter Doherty Fellowship (2006-2010) followed by a Faculty Trust Roper Fellowship (2011-2012). In this time, Dominic established an independent research program focused on complex signalling regulation of microtubule organization. In 2013, Dominic was appointed as a Senior Research Fellow, supported by an ARC Future Fellowship (2013-2016) at the Department of Biochemistry within the Bio21 Institute, University of Melbourne. In 2015, Dominic relocated his research group to the School of Biomedical Science, University of Queensland and is currently appointed as an ARC Future Fellow and Senior Lecturer.

I completed a PhD in Neuroscience with Jack Pettigrew (FRS) at Vision, Touch & Hearing Research Centre followed by an NHMRC Clinical Research Fellowship at Alfred Health & Monash University.

Back in QLD I'm continuing a transdisciplinary research & innovation program to Bring Discoveries of the Brain to Life!

I'm currently focused on developing novel MedTech Biotech diagnostics & therapeutics for enhancing human performance, recovery & resilience with the following projects:

[1] Precision Pain Medicine — the largest genetic study of persistent (chronic) pain in Australia, in collaboration with QIMR Berghofer & Monash University, aims to identify pharmacogenomics causal pathways for the design of personalised therapeutics & effective early intervention approaches (e.g., screening, education, prevention).

[2] Brain Switcha — A digital transdiagnostic biomarker and cloud-based large-scale population phenotyping & analytics platform to improve early intervention strategies in sleep & mental health conditions (esp. at-risk youth cohorts) and recruitment screening for Defence forces.

[3] VCS — vestibulocortical stimulation: A simple, inexpensive, non-invasive & non-pharmacologic neurotherapeutic treatment technique for fibromyalgia (with US colleagues) and other centralised pain syndromes, sleep apnoea, dementia & mental health conditions (e.g., depression, PTSD, bipolar disorder).

I also have >5 years professional services experience providing specialist research performance evaluation, consultation, reporting & training workshops that successfully delivered several major strategic priorities to a large internal & external client base — such as organisational unit leaders/managers at multiple levels (e.g., Centre/Department) and senior executive business missions for national/international strategic partnerships. This work includes mapping, monitoring & benchmarking of research capacity, capabilities/strengths, gaps & collaboration networks (e.g., clinical, corporate & government) across diverse disciplines for Annual & Septennial Departmental Reviews (e.g., patent, policy & clinical guideline citations; external stakeholder engagement including media); ARC Engagement & Impact assessments; and workforce capability development (e.g., recruitment for senior leadership positions and ranking of NHMRC/ARC funding applicants).

In particular, I enjoy meeting & connecting people with a shared vision & commitment towards building innovative & sustainable public-private partnerships to deliver meaningful solutions for the wider community.

I completed my PhD in Neuroscience at UQ in 2009. After this, I undertook postdoctoral training in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) under the mentorship of neurologists at Royal Brisbane & Women's Hospital. In 2012, I received a MND Research Australia Bill Gole Fellowship to develop a research focus to study metabolic dysfunction in MND/ALS. I started my independent research group at UQ in 2015, after receiving the Scott Sullivan MND Research Fellowship to lead a translational program to define the contribution of altered metabolic homeostasis to MND/ALS pathophysiology. In 2017, I relocated my laboratory to the Australian Institute for Bioengineering and Nanotechnology to introduce the use of human stem cells for disease modelling into my reserach program. In 2020, I was awarded a FightMND Mid-Career Research Fellowship to transition into clinical trials.

My current research integrates studies in MND/ALS patients with studies in human-derived cell models (stem cell-derived neurons, human primary myosatellite cells, human myotubes) and mouse models of MND/ALS. I have served as lead investigator or co-investigator on several projects aimed at defining the mechanisms that drive MND/ALS and identifying therapeutic strategies for the disease. Projects have led to the expediting of clinical trials (NCT03506425; NCT04788745, NCT05959850). In 2021, I established the MND at UQ Collective to enhance national and international collaboration, and to facilitate community consultation to drive scientific and clinical discoveries in ALS and FTD (www.uq.edu.au/mnd-collective).

I have received invitations to contribute to high impact review articles (i.e., Brain, Nat Rev Neurol), and have received >20 invitations to speak at conferences including: 33rd International ALS/MND Symposium (2022, Plenary), 64th Japanese Society of Neurology Meeting (2023, Tokyo; Plenary), 3rd International Pan-Asian Consortium for Treatment and Research in ALS (PACTALS) Congress (2023, Kuala Lumpur), 18th International Congress on Neuromuscular Diseases (2024, Perth).

Shaun O’Leary, BPHTY (Hon), MPHTY (Msk), PhD, is an Associate Professor in Physiotherapy between the School of Health and Rehabilitation Sciences at the University of Queensland, and the Royal Brisbane and Women’s Hospital Physiotherapy Department, in Brisbane, Australia. He is also a Specialist Musculoskeletal Physiotherapist (as awarded by the Australian College of Physiotherapists (ACP) in 2008). Shaun is a longstanding member of the Australian Physiotherapy Association and Fellow of the ACP. Shaun is across clinical education at all levels of physiotherapy training. He has had a major teaching role in the University of Queensland’s postgraduate specialty Masters of Physiotherapy (Musculoskeletal and Sports Physiotherapy) programs since 2001, and nationally has served the ACP as an examiner, and former council member and Chair of the Fellowships Program Standing Committee. In 2021 Shaun was awarded a Senior Fellowship within the Higher Education Academy (SFHEA). Shaun has over 130 publications relating to the management of musculoskeletal conditions (including >110 research articles, 6 book chapters, 2 books translated to multiple languages), > 50 conference presentations, nearly AUD$6 million career grant funding, and have delivered over 60 clinical workshops worldwide, and received clinical research awards nationally and internationally, and supervised 13 research higher degrees.

After completing neurology training at the Royal Brisbane & Women’s Hospital(RBWH) in 1995, A/Prof O’Sullivan completed Fellowships in Movement Disorders at the Austin & Repatriation Medical Centre, Melbourne then the National Hospital for Neurology and Neurosurgery, and Middlesex Hospital in London, UK. He was awarded a doctorate in Medicine from Melbourne University in 2000 for studies into surgery for Parkinson’s disease. He returned to the RBWH in 2001 and set up the Movement Disorders Clinical Service which he directs including botulinum toxin and later Friedreich's ataxia clinics, and co-ordinating the Huntington's disease multidisciplinary clinic. Through these clinics he has established collaborations with local, interstate and international researchers in the fields of Parkinson's disease, and other movement disorders and neurodegenerative diseases. He is currently Associate Professor of Medicine at UQ Centre for Clinical Research, currently co-director of the Neurodegenertion Clinical Research Group. A/Prof O'Sullivan past President of the Movement Disorders Society of Australia and New Zealand (MDSANZ), having previously served as Chair of the MDSANZ Clinical Trials and Research Group. He has been is on the Council of the Australian and New Zealand Association of Neurolgists (ANZAN) and previously chaired the ANZAN Scientific Program Committee.